Figure 1From: Co-morbidity but not dysglycaemia reduces quality of life in patients with type-2 diabetes treated with oral mono- or dual combination therapy – an analysis of the DiaRegis registryHRQoL in patients with hypoglycaemia. Legend: Odds Ratios in the lower panel were adjusted for an age, gender and body mass index.Back to article page